Chile vs Turkmenistan: New cases tested for RR-/MDR-TB
Chile
100.0%
in 2024
Turkmenistan
100.0%
in 2022
Chile rank
1st
Turkmenistan rank
1st
New cases tested for RR-/MDR-TB over time
- Chile
- Turkmenistan
How they compare
Chile currently reports 100.0% against 100.0% in Turkmenistan, a difference of 0.0%.
The two have swapped places 3 times across 8 shared years of data; in 2006 it was Chile ahead.
Chile ranks 1st and Turkmenistan ranks 1st of 192 countries.
Across the 3 decades both report, Chile averaged higher in 1 and Turkmenistan in 2.
Head to head by decade
| Decade | Chile | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.2% | 6.0% | 0.8% | Turkmenistan |
| 2010s | 54.8% | 45.0% | 9.8% | Chile |
| 2020s | 94.3% | 100.0% | 5.7% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Chile or Turkmenistan?
- Chile, at 100.0% against 100.0% in Turkmenistan as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Chile and Turkmenistan?
- 0.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Turkmenistan?
- 8 years are reported by both, from 2006 to 2022.
- How do Chile and Turkmenistan rank globally for new cases tested for rr-/mdr-tb?
- Chile ranks 1st and Turkmenistan ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.